Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology

Frontiers in Endocrinology

Endocrinology

Eva Surmacz¹  Michaela Ruth Reagan²  Valentina Guarnotta³ 

[1] Allysta Pharmaceuticals, Inc., Belmont, WA, United States;Center for Molecular Medicine, MaineHealth Institute of Research (MHIR), Scarborough, ME, United States;Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo, Palermo, Italy;

关键词: obesity;    cancer;    animal models;    epidemiology—analytic (risk factors);    global prevalence;   

DOI  :  10.3389/fendo.2023.1258994

 received in 2023-07-14, accepted in 2023-07-31,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Surmacz, Guarnotta and Reagan